Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA: 688266)
58.08
-0.78 (-1.33%)
Sep 6, 2024, 3:00 PM CST
Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Cash & Equivalents | 2,320 | 2,110 | 797.05 | 1,137 | 1,150 | 66.92 | Upgrade
|
Trading Asset Securities | 56.23 | 137.02 | 248.93 | 65.26 | 449.85 | 6 | Upgrade
|
Cash & Short-Term Investments | 2,377 | 2,247 | 1,046 | 1,202 | 1,600 | 72.92 | Upgrade
|
Cash Growth | 6.86% | 114.79% | -12.97% | -24.86% | 2093.61% | -65.53% | Upgrade
|
Accounts Receivable | 130.88 | 101.14 | 88.99 | 62.37 | - | - | Upgrade
|
Other Receivables | 9.36 | 10.89 | 12.51 | 12.45 | 2.62 | 7.03 | Upgrade
|
Receivables | 140.24 | 112.03 | 101.5 | 74.82 | 2.62 | 7.03 | Upgrade
|
Inventory | 141.12 | 110.85 | 98.98 | 51.91 | 23.14 | 6.43 | Upgrade
|
Prepaid Expenses | - | - | - | - | 0.39 | - | Upgrade
|
Other Current Assets | 47.87 | 50.79 | 45.3 | 77.33 | 43.83 | 15.45 | Upgrade
|
Total Current Assets | 2,706 | 2,520 | 1,292 | 1,406 | 1,670 | 101.82 | Upgrade
|
Property, Plant & Equipment | 293.85 | 271.21 | 247.09 | 188.91 | 91.03 | 56.67 | Upgrade
|
Long-Term Investments | 5.99 | 5.99 | 10 | 10 | 10 | - | Upgrade
|
Other Intangible Assets | 59.52 | 69.27 | 91.03 | 116.29 | 129.51 | 135.81 | Upgrade
|
Long-Term Deferred Charges | 28.75 | 16.39 | 20.96 | 13.03 | 4.35 | 0.87 | Upgrade
|
Other Long-Term Assets | 5.82 | 4.02 | 7.48 | 11.78 | 65.82 | 25.1 | Upgrade
|
Total Assets | 3,100 | 2,887 | 1,668 | 1,746 | 1,970 | 320.27 | Upgrade
|
Accounts Payable | 128.86 | 137.73 | 151.72 | 118.19 | 64.96 | 54.03 | Upgrade
|
Accrued Expenses | 67.74 | 74.96 | 67.5 | 48.22 | 30.92 | 16.57 | Upgrade
|
Short-Term Debt | 914.21 | 795.16 | 390.79 | 131.81 | 17.67 | 60 | Upgrade
|
Current Portion of Long-Term Debt | - | 50.56 | 50.04 | 30.03 | - | - | Upgrade
|
Current Portion of Leases | 13.17 | 13.17 | 13.69 | 13.55 | - | - | Upgrade
|
Current Income Taxes Payable | 20.77 | 20.64 | 20.29 | 18.58 | 16.94 | 11.45 | Upgrade
|
Current Unearned Revenue | - | - | 0.28 | 0.36 | - | - | Upgrade
|
Other Current Liabilities | 24.39 | 42.95 | 34.88 | 20.16 | 10.38 | 8.11 | Upgrade
|
Total Current Liabilities | 1,169 | 1,135 | 729.19 | 380.89 | 140.88 | 150.17 | Upgrade
|
Long-Term Debt | - | - | 50.09 | - | 30.03 | - | Upgrade
|
Long-Term Leases | 29.18 | 29.46 | 43.18 | 48.18 | 4.32 | 4.83 | Upgrade
|
Long-Term Unearned Revenue | 14.02 | 11.55 | 45.04 | 48.05 | 83.66 | 66.22 | Upgrade
|
Long-Term Deferred Tax Liabilities | 7.65 | 9.58 | 13.32 | 15.77 | 19.81 | 25.3 | Upgrade
|
Other Long-Term Liabilities | 311.32 | 56.6 | - | - | - | - | Upgrade
|
Total Liabilities | 1,531 | 1,242 | 880.82 | 492.88 | 278.69 | 246.52 | Upgrade
|
Common Stock | 264.71 | 264.71 | 240 | 240 | 240 | 180 | Upgrade
|
Additional Paid-In Capital | 3,353 | 3,353 | 2,222 | 2,205 | 2,174 | 294.98 | Upgrade
|
Retained Earnings | -2,045 | -1,979 | -1,700 | -1,243 | -791.56 | -472.33 | Upgrade
|
Comprensive Income & Other | -5.66 | -5.95 | -2.84 | -6.32 | -5.04 | 0.77 | Upgrade
|
Total Common Equity | 1,567 | 1,633 | 759.12 | 1,196 | 1,618 | 3.43 | Upgrade
|
Minority Interest | 1.32 | 11.98 | 28.37 | 56.76 | 73.86 | 70.32 | Upgrade
|
Shareholders' Equity | 1,568 | 1,645 | 787.49 | 1,253 | 1,692 | 73.75 | Upgrade
|
Total Liabilities & Equity | 3,100 | 2,887 | 1,668 | 1,746 | 1,970 | 320.27 | Upgrade
|
Total Debt | 956.56 | 888.35 | 547.8 | 223.57 | 52.02 | 64.83 | Upgrade
|
Net Cash (Debt) | 1,420 | 1,358 | 498.18 | 978.32 | 1,548 | 8.09 | Upgrade
|
Net Cash Growth | -3.44% | 172.65% | -49.08% | -36.78% | 19021.89% | -96.09% | Upgrade
|
Net Cash Per Share | 5.37 | 5.31 | 2.08 | 4.08 | 6.59 | 0.05 | Upgrade
|
Filing Date Shares Outstanding | 264.71 | 264.71 | 264.49 | 240 | 240 | 240 | Upgrade
|
Total Common Shares Outstanding | 264.71 | 264.71 | 240 | 240 | 240 | 180 | Upgrade
|
Working Capital | 1,537 | 1,385 | 562.57 | 1,025 | 1,529 | -48.34 | Upgrade
|
Book Value Per Share | 5.92 | 6.17 | 3.16 | 4.98 | 6.74 | 0.02 | Upgrade
|
Tangible Book Value | 1,508 | 1,564 | 668.09 | 1,080 | 1,488 | -132.38 | Upgrade
|
Tangible Book Value Per Share | 5.70 | 5.91 | 2.78 | 4.50 | 6.20 | -0.74 | Upgrade
|
Buildings | 41.93 | 41.93 | 41.93 | 41.21 | - | 40.92 | Upgrade
|
Machinery | 143.04 | 125.42 | 121.74 | 96.02 | - | 32.59 | Upgrade
|
Construction In Progress | 146.91 | 135.83 | 86.67 | 27.25 | - | 0.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.